Berke Search
The Berke Report: Clinical and Commercial Updates for the First Week of May 2023
FibroGen Announces Results for MATTERHORN, a Phase 3 Clinical Studyof Roxadustat forthe Treatment of Anemia in Patients with...
top of page
Berke Search
- Apr 17
- 6 min
The Berke Report: Clinical and Commercial Updates for Week Four of April 2023
Pfizer snags FDA approval for expanded pneumococcal vaccine (pharmamanufacturing) Pfizer announced this week that the FDA has approved...
4 views0 comments
bottom of page